glp-1 agonist medications Receptor Agonists and Research to Treat Overeating and Substance Use Disorders Benefits and Risks of GLP-1

There was a reduction in plasma glucose and HbA1c levels at the three highest doses of retatrutide and a dose-dependent reduction in body weight [63]

There are various side-effects both mild and serious to taking GLP-1 drugs, including nausea and dizziness to pancreatitis and medullary thyroid cancer

These trials also demonstrated a significant reduction in C-Reactive Protein (CRP) levels, reinforcing the hypothesis that suppressing the pro-inflammatory state may yield substantial clinical benefits in this patient population

7 This preclinical work has now been translated to a population of patients with raised ICP due to IIH

Asmar A, Simonsen L, Asmar M, Madsbad S, Holst JJ, Frandsen E, et al